| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.93B | 2.15B | 2.17B | 2.80B | 1.10B | 1.48B |
| Gross Profit | 887.87M | 858.48M | 654.80M | 1.10B | 409.13M | 489.20M |
| EBITDA | 547.05M | 519.81M | 503.00M | 558.05M | 343.97M | 286.00M |
| Net Income | 113.01M | 109.37M | 122.40M | 132.15M | 56.80M | 25.00M |
Balance Sheet | ||||||
| Total Assets | 0.00 | 7.43B | 6.82B | 5.97B | 5.74B | 4.39B |
| Cash, Cash Equivalents and Short-Term Investments | 33.82M | 33.82M | 34.30M | 33.15M | 79.96M | 170.30M |
| Total Debt | 0.00 | 3.57B | 3.11B | 2.59B | 3.13B | 1.32B |
| Total Liabilities | -3.50B | 3.93B | 3.42B | 2.85B | 3.26B | 1.93B |
| Stockholders Equity | 3.50B | 3.50B | 3.40B | 3.12B | 2.47B | 2.45B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -76.66M | -199.03M | 313.10M | -1.52B | 53.80M |
| Operating Cash Flow | 0.00 | -45.74M | 24.76M | 514.57M | -680.59M | 55.10M |
| Investing Cash Flow | 0.00 | -31.52M | -228.89M | -201.48M | -854.14M | -9.30M |
| Financing Cash Flow | 0.00 | 76.86M | 191.54M | -652.46M | 1.44B | 58.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
67 Neutral | ₹2.54B | 6.10 | ― | ― | 21.76% | 113.02% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
57 Neutral | ₹5.15B | 29.63 | ― | ― | -10.78% | -4.71% | |
56 Neutral | ₹2.33B | 8.62 | ― | ― | 1.70% | -71.32% | |
52 Neutral | ₹3.48B | -16.89 | ― | 0.36% | -13.84% | -149.34% | |
49 Neutral | ₹2.53B | 20.77 | ― | ― | -39.31% | -110.49% |
Davangere Sugar Company Limited held its 54th Annual General Meeting on September 30, 2025, where the audited financial statements for the fiscal year ending March 31, 2025, were presented and adopted. The meeting’s voting results showed strong approval, with a high percentage of votes in favor of the resolutions, indicating robust shareholder support and confidence in the company’s financial health and management.